MedPath

Clinical study using preserved serum samples obtained in clinical trials of absorbed influenza vaccine (H5N1).

Not Applicable
Completed
Conditions
H5N1 influenza
Registration Number
JPRN-jRCT1090220048
Lead Sponsor
ational Hospital Organization Mie National Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
350
Inclusion Criteria

Subjects who participated in one of the following clinical trials of influenza vaccine: BK-PIFA/002, KIB-PIA02, BK-PIFA003, or KIB-PIA03.
Subjects must also meet the following conditions:
1) Subjects who consented to this study or subjects for whom the use of their serum samples in this study has been approved by the ethics committee and representatives of the study institution.
2) Subjects whose serum samples are available.

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination of possible pyrogenic substances.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath